Agenus
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agenus and other ETFs, options, and stocks.About AGEN
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777.
CEOGaro H. Armen
CEOGaro H. Armen
Employees316
Employees316
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded1994
Founded1994
Employees316
Employees316
AGEN Key Statistics
Market cap137.73M
Market cap137.73M
Price-Earnings ratio-1.96
Price-Earnings ratio-1.96
Dividend yield—
Dividend yield—
Average volume407.77K
Average volume407.77K
High today$4.21
High today$4.21
Low today$3.97
Low today$3.97
Open price$4.17
Open price$4.17
Volume238.77K
Volume238.77K
52 Week high$7.34
52 Week high$7.34
52 Week low$1.38
52 Week low$1.38
Stock Snapshot
With a market cap of 137.73M, Agenus(AGEN) trades at $4.05. The stock has a price-to-earnings ratio of -1.96.
During the trading session on 2025-12-04, Agenus(AGEN) shares reached a daily high of $4.21 and a low of $3.97. At a current price of $4.05, the stock is +2.0% higher than the low and still -3.8% under the high.
Trading activity shows a volume of 238.77K, compared to an average daily volume of 407.77K.
The stock's 52-week range extends from a low of $1.38 to a high of $7.34.
The stock's 52-week range extends from a low of $1.38 to a high of $7.34.
People also own
Based on the portfolios of people who own AGEN. This list is generated using Robinhood data, and it’s not a recommendation.